In contrast, this review is designed to address these limitations by systematically elucidating the structure-immunomodulation relationship of APS, positioning TLR4 as a central mediator and validating this interaction via modern analytical techniques. The gene discussed is TLR4; the disease is autoimmune polyendocrinopathy.